Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
discard any unused portion [1]
Temporarily lowering your dose
The Discovery and Development of Human GLP-1 Product details Product details Edition: 1 Latest edition Published: March 3, 2026 Language: English About the author About the author JH Jens Juul Holst Jens Juul Holst is Professor of Medical Physiology at the Department of Biomedical Sciences, University of Copenhagen
Looking more closely at people living with diabetes, a recent meta analysis of 11 randomized controlled trials found that GLP-1s significantly reduced both cardiovascular and kidney events (such as kidney failure)
It not only provides almost immediate balancing of hormones, including GLP-1, [but] it also addresses long-term metabolic health by activating the same enzyme created by endurance exercise. The bottom line
This results in a rise in glucose levels in the end part of the intestine, which then triggers an increase in the release of GLP-1 from L cells, promoting growth (Wu et al., 2017)
US$ 27.41
US$ 22.40
US$ 28.18
